Treatment of Retinoblastoma in 2015 Agreement and Disagreement

被引:177
作者
Abramson, David H. [1 ,2 ]
Shields, Carol L. [3 ]
Munier, Francis L. [4 ]
Chantada, Guillermo L. [5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10065 USA
[2] Weill Cornell Med Ctr, Dept Ophthalmol, New York, NY USA
[3] Thomas Jefferson Univ, Wills Eye Hosp, Ocular Oncol Serv, Philadelphia, PA 19107 USA
[4] Jules Gonin Eye Hosp, Fac Biol & Med Lausanne, Lausanne, Switzerland
[5] Hosp JP Garrahan, Res Inst, Buenos Aires, DF, Argentina
关键词
OPHTHALMIC ARTERY CHEMOTHERAPY; 2ND NONOCULAR TUMORS; INTRAARTERIAL CHEMOTHERAPY; INTRAOCULAR RETINOBLASTOMA; BILATERAL RETINOBLASTOMA; INTRAVITREAL INJECTION; CURRENT MANAGEMENT; RETINAL FUNCTION; PHASE-I/II; THERAPY;
D O I
10.1001/jamaophthalmol.2015.3108
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this report collectively represent their management strategies with an emphasis on areas of agreement and disagreement. Ophthalmic artery chemosurgery and intravitreous chemotherapy have completely replaced external beam radiotherapy, reduced the use of systemic chemotherapy, and diminished enucleations by 90% without evidence of compromising patient survival.
引用
收藏
页码:1341 / 1347
页数:7
相关论文
共 52 条
[1]   A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma - Initial results [J].
Abramson, David H. ;
Dunkel, Ira J. ;
Brodie, Scott E. ;
Kim, Jonathan W. ;
Gobin, Y. Pierre .
OPHTHALMOLOGY, 2008, 115 (08) :1398-1404
[2]   Retinoblastoma: Saving Life with Vision [J].
Abramson, David H. .
ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 :171-184
[3]   Ophthalmic Artery Chemosurgery for Less Advanced Intraocular Retinoblastoma: Five Year Review [J].
Abramson, David H. ;
Marr, Brian P. ;
Brodie, Scott E. ;
Dunkel, Ira ;
Palioura, Sotiria ;
Gobin, Y. Pierre .
PLOS ONE, 2012, 7 (04)
[4]   Bilateral Superselective Ophthalmic Artery Chemotherapy for Bilateral Retinoblastoma: Tandem Therapy [J].
Abramson, David H. ;
Dunkel, Ira J. ;
Brodie, Scott E. ;
Marr, Brian ;
Gobin, Y. Pierre .
ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (03) :370-372
[5]   A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma [J].
Abramson, DH ;
Frank, CM ;
Dunkel, IJ .
OPHTHALMOLOGY, 1999, 106 (10) :1947-1950
[6]   Second nonocular tumors in survivors of bilateral retinoblastoma - A possible age effect on radiation-related risk [J].
Abramson, DH ;
Frank, CM .
OPHTHALMOLOGY, 1998, 105 (04) :573-579
[7]   Retinoblastoma in the 20th century: Past success and future challenges - The Weisenfeld lecture [J].
Abramson, DH .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (08) :2684-2691
[8]   Update on retinoblastoma [J].
Abramson, DH ;
Schefler, AC .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2004, 24 (06) :828-848
[9]   Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma [J].
Abramson, DH ;
Beaverson, KL ;
Chang, ST ;
Dunkel, IJ ;
McCormick, B .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (09) :1316-1323
[10]  
ABRAMSON DH, 1984, OPHTHALMOLOGY, V91, P1351